Anthropic’s head of economics just explained why we haven’t seen a white-collar bloodbath — yet25 July 2026
Why Blood Test For Early Detection Of Alzheimer’s Disease MattersBy Press Room2 June 2025 Set to launch this month, a recently approved blood test to detect biomarkers for Alzheimer’s disease could bring diagnosis into…
UK’s NICE Says Alzheimer’s Disease Drug Kisunla Is Not Cost-EffectiveBy Press Room2 November 2024 The United Kingdom medicines authority approved the Alzheimer’s disease drug Kisunla (donanemab) last week for certain patients. This follows the…